TickerFactsScreenerDevelopers

ENANTA PHARMACEUTICALS INC (ENTA) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2011: $445.0K2012: $252.0K2013: $606.0K2014: $1.03M2015: $2.34M2016: $4.74M2017: $2.51M2018: $2.98M2019: $5.42M2020: $1.45M2021: $750.0K2022: $2.12M2023: $9.06M2024: $17.95M2025: $12.90M$12.90M
2011Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$12.90M-28.1%
2024$17.95M+98.1%
2023$9.06M+326.3%
2022$2.12M+183.3%
2021$750.0K-48.1%
2020$1.45M-73.3%
2019$5.42M+81.7%
2018$2.98M+19.0%
2017$2.51M-47.1%
2016$4.74M+102.8%
2015$2.34M+127.2%
2014$1.03M+69.6%
2013$606.0K+140.5%
2012$252.0K-43.4%
2011$445.0K—